Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...

Individuals taking warfarin who engaged in weekly patient self-testing (PST) had significant improvement in control of warfarin compared to patients who had variable (1–4 tests per month) self-testing ...

Globally, how many patients are estimated to be taking Warfarin and what are the main reasons the drug is prescribed? There are roughly 10 million people worldwide taking Warfarin, accounting for more ...

Digital health specialist Inhealthcare is bringing to market the first self-testing mobile app for warfarin users that connects directly to doctors. The Harrogate, North Yorkshire-based company has ...

Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range. Point-of-care, home international normalized ...

Authors say findings warrant re-examining approach to managing anticoagulation in older adults. (HealthDay News) — Having a supratherapeutic international normalized ratio (INR) while taking warfarin ...

A new recall has been issued CoaguChek XS PT test strips, used to monitor international normalized ratio (INR) in patients taking warfarin, due to inaccurately high readings. Roche Diagnostics ...

Patients have poor knowledge of warfarin, which may increase their risk of serious side effects, according to new research. Patients have poor knowledge of warfarin which may increase their risk of ...

A voluntary recall of certain test strips made by Roche Diagnostics for use with its CoaguChek warfarin anticoagulation meters is now categorized as Class I, the US Food and Drug Administration has ...

Northbrook, Ill - The US FDA has approved a new genetic test to help assess warfarin sensitivity [1]. The FDA notes that one-third of patients metabolize warfarin more slowly than others and therefore ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA – All-cause hospital admissions were reduced by nearly one-third following early genetic testing for two ...